Is ICL Surgery Safe? Safety Evidence, Global Adoption, and the Japanese Standard of Care

Free Email Consultation: Check Your Eligibility

I. Introduction: The Central Question—Is ICL Surgery Safe?

For anyone considering permanent vision correction, the question "Is ICL surgery safe?" is paramount. The Implantable Collamer Lens (ICL) has moved far beyond being an experimental treatment; it is now a globally established procedure. Its reputation for safety is built not just on high success rates, but on solid clinical evidence, biological compatibility, and a proven system for risk mitigation.

This article explores the fundamental safety rationale of ICL, examines its worldwide acceptance, and explains why leading Japanese ophthalmologists often prioritize ICL over traditional laser eye surgery (like LASIK and PRK) due to its superior safety profile and preservation of the eye's natural anatomy.

II. The Rationale: Why ICL's Mechanism is Inherently Safe

The inherent safety of ICL is rooted in its fundamental surgical approach, which contrasts sharply with laser ablation techniques.

1. Tissue Preservation is Key to Safety

Unlike laser surgeries, which correct vision by permanently removing corneal tissue (ablation), ICL is an additive procedure. It involves inserting a microscopic lens into the eye, leaving the cornea—the eye’s main structural component—untouched. This tissue preservation is crucial for safety:

• Avoids Ectasia Risk: By preserving the cornea's thickness and biomechanical strength, ICL eliminates the risk of post-LASIK/PRK ectasia (corneal bulging), a severe, sight-threatening complication associated with excessive tissue removal.

• Reversibility: The lens can be safely removed or exchanged, offering the patient an ultimate safety net that allows the eye to return to its pre-surgical state if necessary—a feature that no laser procedure can offer.

2. Biocompatibility and Longevity

The lens itself is made of Collamer, a proprietary material that includes a small amount of collagen. This makes the ICL highly biocompatible with the eye's internal environment. Collamer does not cause rejection, rarely calcifies, and is designed to remain stable and effective within the eye for the patient's entire lifetime, backed by over two decades of clinical use.

III. Global Adoption and Safety Evidence

ICL is recognized by international regulatory bodies and is highly common, particularly in Asia. Since its initial introduction, over two million ICLs have been successfully implanted globally, a figure that continues to grow rapidly.

Clinical studies and meta-analyses consistently report that ICL surgery has a high efficacy and safety profile, with patient satisfaction rates frequently exceeding 95%. This widespread adoption and accumulated data over decades serve as powerful evidence of its reliability and safety.

IV. The Japanese Preference: Prioritizing ICL Safety

While skilled in all refractive procedures, Japanese specialists often exhibit a strong clinical preference for ICL, especially for high prescriptions, based on a conservative medical philosophy:

• Preservation Philosophy: The Japanese medical ethos prioritizes minimal invasiveness and the preservation of native tissue. ICL, by keeping the cornea intact, aligns perfectly with this goal of maintaining the eye's long-term health and structural integrity.

• Superior Results for High Myopia: Japan has a high prevalence of high myopia. For these patients, ICL provides significantly better visual quality and safety than laser ablation, which would require dangerously thinning the cornea to achieve the same result.

• Risk Mitigation Mastery: Japanese surgeons rely on ICL's reversibility. They view the ability to remove the lens as the ultimate risk mitigation strategy, giving them confidence that they can manage virtually any long-term complication without irreversible loss of corneal tissue.

V. Managing Potential Complications and Risks and their Mitigation

Despite its strong safety profile, it is critical to address the specific potential ICL surgery risks. The safety of ICL lies in the expertise used to prevent and manage these issues.

Potential Risk	Description	Japanese Mitigation Protocol
Cataract Formation	Risk increases if the ICL vault is too low, causing contact with the natural lens.	Precision Sizing: Utilizing AS-OCT to precisely calculate the lens size, ensuring a stable, adequate vault that minimizes long-term contact risk.
IOP Elevation/Glaucoma	Risk increases if the ICL vault is too high, potentially impeding the eye's natural drainage angle.	Meticulous Monitoring: Immediate and long-term post-operative monitoring of IOP. Prompt intervention (medication or ICL exchange) if pressure rises, preventing damage.
Infection (Endophthalmitis)	A rare but serious infection risk associated with any intraocular surgery.	Strict Aseptic Protocols: Adherence to Japan's globally recognized, rigorous sterile surgical standards to reduce infection rates to the absolute minimum.
Need for Lens Exchange	Required if the vault is severely suboptimal or if the patient later develops a cataract.	Expert Reversibility: Japanese surgeons possess extensive experience and high proficiency in safely performing ICL removal or exchange procedures, honoring the lens's key safety feature.

VI. Conclusion: The Verdict—Safety Confirmed by Expertise

The answer to "Is ICL surgery safe?" is a resounding yes, provided the procedure is executed with precision and a commitment to long-term care. The ICL’s inherent design—its preservation of the cornea and its reversibility—provides a foundational level of safety unmatched by laser procedures.

By choosing the Japan Standard of ophthalmic care, patients ensure their surgery is backed by leading expertise in diagnostics, conservative risk assessment, and mastery over advanced mitigation techniques, cementing ICL as a safe, effective, and future-proof vision correction solution.

This article was reviewed by

Dr. Daiki Sakai, MD

Free Email Consultation: Check Your Eligibility